＜研究開発・ﾒﾃﾞｨｶﾙｱﾌｪｱｰｽﾞ統括本部＞Health Outcomes/Real World Evidence Scientist／Scientist・Sr. Scientist・Principal Scientist・Sr. Principal Scientist／神戸本社　東京支社 at Eli Lilly and Company

Kobe, Hyogo, Japan

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalIndustries

Requirements

(Not provided in job description)

Responsibilities

Develops and oversees local HEOR/RWE strategy for compounds in the Lilly portfolio in Japan in the relevant therapeutic area(s) that is aligned with local product strategy and global/regional HEOR/RWE strategy
Drives sustained integration of HEOR/RWE from early clinical development through commercialization depending on focus of the assigned project or therapeutic area
Formulates and drives Patient Focused Outcome, Real World Evidence, and/or economic value strategies for priority products
Provides strategic direction to address complex health outcomes challenges
Leads local HEOR/RWE evidence planning and execution for individual compounds/products across the development and commercialization lifecycle to support drug development, optimize pricing and access, and maximize post-launch product value in collaboration with local cross functional team and/or global VEO/VEO International
Develops and designs HEOR/RWE studies that can address important gaps for the products, is scientifically robust and feasible, and meet relevant quality standards
Applies technical expertise appropriate for the role (e.g., scope or depth in statistical analysis, economic modeling, clinical trials, PFO development, observational/epidemiologic research methodologies) within a therapeutic area
Ensures sustainable delivery of planned evidence in a timely manner
Demonstrates scientific leadership in evidence strategy, planning, study development and execution
Links technical expertise with business acumen and establishes and maintains strategic relationships with key internal and external decision makers
Effectively integrates with and influences key business partners and external stakeholders to achieve goals and outcomes
Promotes strategic integration into global for both projects and functional activities
Applies unprecedented innovative approaches with taking a risk to deliver best results

Skills

HEOR

RWE

Real World Evidence

Health Economics

Outcomes Research

Statistical Analysis

Economic Modeling

Clinical Trials

Observational Research

Epidemiologic Research

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free